Sree Harsha Tirumani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sree Harsha Tirumani has a total of 185 co-authors. Here are the top co-authors by number of shared publications:
- Nikhil H. Ramaiya
Department of Radiology, University Hospitals Cleveland Medical Center/Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA
19 shared publications - Daniel Arnold Smith
Department of Radiology, University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH
7 shared publications - Dheeman Futela
Department of Radiology and Biomedical Imaging, Yale School of Medicine
4 shared publications - Elias George Kikano
Emory University, Department of Radiology and Imaging Science, 100 Woodruff Circle, Atlanta, GA 30322 USA
4 shared publications - Kaustav Bera
Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH
4 shared publications Nikhil H. Ramaiya
Case Western Reserve University School of Medicine, Cleveland, OH
4 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Springer Nature in Pediatric Radiology
- p. 1-16
Advanced MRI methods for children and young adults with autosomal recessive polycystic kidney disease (ARPKD) to support future multi-center clinical trials
- 28 July 2026
- Published by Springer Nature in Pediatric Radiology
- p. 1-16
Open AccessAdvanced MRI methods for children and young adults with autosomal recessive polycystic kidney disease (ARPKD) to support future multi-center clinical trials
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250131
Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management
Renal oncocytic neoplasms pose diagnostic challenges due to overlapping imaging features, and radiologists should be aware of recent classification updates, imaging findings, biopsy limitations, and evolving management strategies.
- 1 May 2026
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 46 (5) , e250131
Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management
Renal oncocytic neoplasms pose diagnostic challenges due to overlapping imaging features, and radiologists should be aware of recent classification updates, imaging findings, biopsy limitations, and evolving management strategies.
- 7 April 2026
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 55 (4) , 487-493
Inspiring the next generation of academic radiologists: A leadership journey
- 7 April 2026
- Published by Elsevier in Current Problems in Diagnostic Radiology
- Vol. 55 (4) , 487-493
Inspiring the next generation of academic radiologists: A leadership journey
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (1) , e252547
Characterization of Clinically Significant Prostate Cancer in the Peripheral Zone Using Rapid B 1 -Insensitive MR Fingerprinting
Quantitative MRI evaluation of prostate lesions using rapid, B 1 -insensitive prostate MR fingerprinting and apparent diffusion coefficient mapping differentiated clinically significant cancers from clinically insignificant lesions.
- 1 April 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (1) , e252547
Characterization of Clinically Significant Prostate Cancer in the Peripheral Zone Using Rapid B 1 -Insensitive MR Fingerprinting
Quantitative MRI evaluation of prostate lesions using rapid, B 1 -insensitive prostate MR fingerprinting and apparent diffusion coefficient mapping differentiated clinically significant cancers from clinically insignificant lesions.
- Open Access
- 3 March 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-10
Tumor metrics imaging core labs: primer for radiologists
Imaging biomarkers have emerged as increasingly important endpoints in cancer clinical trials. Incorporating tumor metric reads as part of routine clinical reads by on-site radiologists for cancer clinical trials has several challenges which can be addressed by tumor metrics imaging core lab. Despite the operational and financial challenges inherent in establishing and maintaining tumor metrics imaging core labs, including workflow complexities, infrastructure demands, and data security considerations, these facilities confer significant advantages including accelerated trial timelines, improved regulatory compliance, and the creation of interdisciplinary research environments. Moreover, the integration of artificial intelligence within tumor metrics imaging core labs offers enhanced image analysis, predictive modeling, and improved trial efficiency. This article provides a comprehensive review of the role of tumor metrics imaging core labs in clinical trials and provides an overview of the key components involved in setting up a core lab. We will also briefly present the challenges in the successful operation of a tumor metrics imaging core lab and delve into the potential solutions, including the integration of AI tools for clinical trials.
- 3 March 2026
- Published by Springer Nature in Abdominal Radiology
- p. 1-10
Open AccessTumor metrics imaging core labs: primer for radiologists
Imaging biomarkers have emerged as increasingly important endpoints in cancer clinical trials. Incorporating tumor metric reads as part of routine clinical reads by on-site radiologists for cancer clinical trials has several challenges which can be addressed by tumor metrics imaging core lab. Despite the operational and financial challenges inherent in establishing and maintaining tumor metrics imaging core labs, including workflow complexities, infrastructure demands, and data security considerations, these facilities confer significant advantages including accelerated trial timelines, improved regulatory compliance, and the creation of interdisciplinary research environments. Moreover, the integration of artificial intelligence within tumor metrics imaging core labs offers enhanced image analysis, predictive modeling, and improved trial efficiency. This article provides a comprehensive review of the role of tumor metrics imaging core labs in clinical trials and provides an overview of the key components involved in setting up a core lab. We will also briefly present the challenges in the successful operation of a tumor metrics imaging core lab and delve into the potential solutions, including the integration of AI tools for clinical trials.
- Open Access
- 1 March 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e251404
Noninvasive Differentiation of Indolent from Aggressive Renal Neoplasms with MR Fingerprinting Combined with Diffusion/Perfusion MRI
Kidney T1 and T2 relaxation times extracted from MR fingerprinting provided complementary information for noninvasive differentiation of indolent versus aggressive renal neoplasms.
- 1 March 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e251404
Open AccessNoninvasive Differentiation of Indolent from Aggressive Renal Neoplasms with MR Fingerprinting Combined with Diffusion/Perfusion MRI
Kidney T1 and T2 relaxation times extracted from MR fingerprinting provided complementary information for noninvasive differentiation of indolent versus aggressive renal neoplasms.
- 1 November 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (6) , e250174
Review of Fusariosis in Patients with Hematologic Malignancies
This review provides a multimodal overview of the multiorgan manifestations of invasive fusariosis in patients with hematologic malignancies, outlines its clinical presentations, and summarizes current treatment approaches based on previously published cases.
- 1 November 2025
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 7 (6) , e250174
Review of Fusariosis in Patients with Hematologic Malignancies
This review provides a multimodal overview of the multiorgan manifestations of invasive fusariosis in patients with hematologic malignancies, outlines its clinical presentations, and summarizes current treatment approaches based on previously published cases.
- 26 September 2025
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 50 (2) , 301-307
Revisiting MRI Claustrophobia
Claustrophobia during MRI is a well-documented challenge that affects diagnostic accuracy and patient care. Each year, nearly 2 million MRI scans are disrupted due to anxiety, thus leading to early termination of the scan, image degradation from motion, and increasing healthcare costs. This review examines the prevalence of MRI-related claustrophobia, along with the financial and operational burdens. This review also highlights the latest strategies to improve patient tolerance, which range from technological advancements, behavioral techniques and pharmacological interventions, all of which show promise in reducing scan-related distress. Ultimately, a holistic patient-centered approach is key to optimizing both imaging efficiency and the overall MRI experience.
- 26 September 2025
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 50 (2) , 301-307
Revisiting MRI Claustrophobia
Claustrophobia during MRI is a well-documented challenge that affects diagnostic accuracy and patient care. Each year, nearly 2 million MRI scans are disrupted due to anxiety, thus leading to early termination of the scan, image degradation from motion, and increasing healthcare costs. This review examines the prevalence of MRI-related claustrophobia, along with the financial and operational burdens. This review also highlights the latest strategies to improve patient tolerance, which range from technological advancements, behavioral techniques and pharmacological interventions, all of which show promise in reducing scan-related distress. Ultimately, a holistic patient-centered approach is key to optimizing both imaging efficiency and the overall MRI experience.
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (7)
Population-Specific Radiomics From Biparametric Magnetic Resonance Imaging Improves Prostate Cancer Risk Stratification in African American Men
Purpose: To quantify population-specific differences in prostate cancer (PCa) presentation between African American (AA) and White (W) men on MRI using radiomics. Materials and Methods: We identified N = 149 men with PCa who underwent 3T MRI, a confirmatory biopsy and for whom self-reported race was available. Patient studies were partitioned into training (DTr) and hold-out test set (DTe). Three hundred radiomic features quantifying textural patterns were extracted from radiologist delineated PCa regions of interest (ROI) on biparametric MRI. Features with significant differences (P < .05) between clinically significant (csPCa) and insignificant (ciPCa) PCa were identified. Machine learning models were trained separately for AA and W men (CAA, CW) on DTr to distinguish csPCa and ciPCa. Validation on DTe was assessed for AUC and compared against a population agnostic model (CPA) in combination with clinical parameters (age, PSA, Prostate Imaging Reporting and Diagnostic System and tumor volume). Results: Radiomic features from PCa ROIs on biparametric MRI associated with csPCa were observed to be different in AA compared with W men, especially in the peritumoral region. Population-specific radiomic models outperformed similarly trained CPA models (AUC = 0.84, 0.57 with CAA, CPA; P < .05) in AA men on DTe. Similar findings were observed for W men (AUC = 0.71, 0.60 with CW, CPA; P < .05). Integrating clinical and radiomics further improved the risk stratification for AA men (AUC = 0.90) and W men (AUC = 0.75). Conclusions: Accounting for population-specific differences in radiomics may enable improved PCa risk stratification at MRI among AA men compared with a population agnostic approach.
- 1 July 2025
- Published by Wolters Kluwer Health in JU Open Plus
- Vol. 3 (7)
Open AccessPopulation-Specific Radiomics From Biparametric Magnetic Resonance Imaging Improves Prostate Cancer Risk Stratification in African American Men
Purpose: To quantify population-specific differences in prostate cancer (PCa) presentation between African American (AA) and White (W) men on MRI using radiomics. Materials and Methods: We identified N = 149 men with PCa who underwent 3T MRI, a confirmatory biopsy and for whom self-reported race was available. Patient studies were partitioned into training (DTr) and hold-out test set (DTe). Three hundred radiomic features quantifying textural patterns were extracted from radiologist delineated PCa regions of interest (ROI) on biparametric MRI. Features with significant differences (P < .05) between clinically significant (csPCa) and insignificant (ciPCa) PCa were identified. Machine learning models were trained separately for AA and W men (CAA, CW) on DTr to distinguish csPCa and ciPCa. Validation on DTe was assessed for AUC and compared against a population agnostic model (CPA) in combination with clinical parameters (age, PSA, Prostate Imaging Reporting and Diagnostic System and tumor volume). Results: Radiomic features from PCa ROIs on biparametric MRI associated with csPCa were observed to be different in AA compared with W men, especially in the peritumoral region. Population-specific radiomic models outperformed similarly trained CPA models (AUC = 0.84, 0.57 with CAA, CPA; P < .05) in AA men on DTe. Similar findings were observed for W men (AUC = 0.71, 0.60 with CW, CPA; P < .05). Integrating clinical and radiomics further improved the risk stratification for AA men (AUC = 0.90) and W men (AUC = 0.75). Conclusions: Accounting for population-specific differences in radiomics may enable improved PCa risk stratification at MRI among AA men compared with a population agnostic approach.
- Open Access
- 5 June 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (12) , 6106-6118
10 mm (PI-RADS v2.1) versus 15 mm (PI-RADS v1.0) tumor capsule contact length in predicting extracapsular extension in prostate cancer: Meta-analysis and systematic review
Objective: To determine the diagnostic performance of tumor capsule contact length (TCCL) and to determine its optimal cut-off on prostate MRI to predict extra-capsular extension (ECE) at histopathology of radical prostatectomy specimen in patients with prostate cancer. Materials and methods: An electronic search of the PUBMED and EMBASE databases was performed until December 31, 2024 to identify studies analyzing TCCL as a predictor of ECE on prostate MRI. Pooled sensitivity and specificity of all studies were plotted in a hierarchical summary receiver operating characteristic plot and the risk of ECE was evaluated using bivariate random-effects meta-analysis. Meta-regression analysis for various TCCL cut-offs was performed. Results: Twenty-three eligible studies were found. Reported sensitivity (between 47 − 94%) and specificity (between 46 − 88%) showed significant heterogeneity between studies, without evident threshold effect. Pooled sensitivity and specificity of TCCL for predicting ECE was 76.3% and 68.8% respectively with AUC of 0.787 for the summary ROC curve. Meta-regression analysis showed no significant difference in diagnostic performance according to various TCCL cutoffs, measurement methods, or ISUP grade distribution. Studies with 14 mm threshold had similar sensitivity (73%), but greater specificity (74% vs. 70%) and diagnostic odds ratio (8.3 vs. 6.5), when compared to 10 mm threshold. Conclusion: TCCL on MRI has reasonable pooled sensitivity and specificity to predict ECE. While sensitivity remained moderately high for all TCCL thresholds, specificity at 14 mm (cutoff close to 15 mm suggested by PI-RADS v1.0) threshold was greater than that at 10 mm (cutoff suggested by PIRADS v2.1). This cutoff can be helpful in developing objective likelihood scores for ECE prediction on MRI.
- 5 June 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (12) , 6106-6118
Open Access10 mm (PI-RADS v2.1) versus 15 mm (PI-RADS v1.0) tumor capsule contact length in predicting extracapsular extension in prostate cancer: Meta-analysis and systematic review
Objective: To determine the diagnostic performance of tumor capsule contact length (TCCL) and to determine its optimal cut-off on prostate MRI to predict extra-capsular extension (ECE) at histopathology of radical prostatectomy specimen in patients with prostate cancer. Materials and methods: An electronic search of the PUBMED and EMBASE databases was performed until December 31, 2024 to identify studies analyzing TCCL as a predictor of ECE on prostate MRI. Pooled sensitivity and specificity of all studies were plotted in a hierarchical summary receiver operating characteristic plot and the risk of ECE was evaluated using bivariate random-effects meta-analysis. Meta-regression analysis for various TCCL cut-offs was performed. Results: Twenty-three eligible studies were found. Reported sensitivity (between 47 − 94%) and specificity (between 46 − 88%) showed significant heterogeneity between studies, without evident threshold effect. Pooled sensitivity and specificity of TCCL for predicting ECE was 76.3% and 68.8% respectively with AUC of 0.787 for the summary ROC curve. Meta-regression analysis showed no significant difference in diagnostic performance according to various TCCL cutoffs, measurement methods, or ISUP grade distribution. Studies with 14 mm threshold had similar sensitivity (73%), but greater specificity (74% vs. 70%) and diagnostic odds ratio (8.3 vs. 6.5), when compared to 10 mm threshold. Conclusion: TCCL on MRI has reasonable pooled sensitivity and specificity to predict ECE. While sensitivity remained moderately high for all TCCL thresholds, specificity at 14 mm (cutoff close to 15 mm suggested by PI-RADS v1.0) threshold was greater than that at 10 mm (cutoff suggested by PIRADS v2.1). This cutoff can be helpful in developing objective likelihood scores for ECE prediction on MRI.